Cannula Market Size, Share & Growth Analysis Report 2024-2032

IMARC Group's report titled "Cannula Market Report by Product (Cardiac Cannulas, Nasal Cannulas, Vascular Cannulas, Dermatology Cannulas, Arthroscopy Cannulas, and Others), Type (Neonatal Cannulas, Straight Cannulas, Winged Cannula, Wing with Port Cannula, and Others), Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), Material (Plastic (PVC) Cannulas, Silicone Cannulas, Metal Cannulas (Stainless Steel)), Application (Cardiovascular Surgery, Oxygen Therapy, General Surgery, Cosmetic/Plastic Surgery, Orthopedic Surgery, and Others), End-User (Hospitals, Ambulatory Surgery Centers (ASCs), and Others), and Region 2024-2032". The global cannula market size reached US$ 159.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 267.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cannula-market/requestsample

Factors Affecting the Growth of the Cannula Industry:

• Increasing Demand for Minimally Invasive (MI) Surgeries:

The growing preference for minimally invasive (MI) surgeries among the masses for their advantages, such as smaller incisions, reduced pain, quicker recovery, and lower risk of infection, is driving the demand for cannulas. Cannulas, serving as vital components in the administration of medications, removal of fluid, or collection of samples, are indispensable in surgeries including liposuction, rhinoplasty, and various cardiovascular operations. The shift towards MI surgeries is supported by patient preference for less traumatic surgical experiences and the focus of the healthcare industry on reducing hospital stay durations and recovery times. This is bolstered by technological advancements that enhance the efficacy and safety of cannula-based procedures, making them more accessible and preferred by healthcare professionals.

• Technological Advancements in Cannula Design:

Modern cannulas are designed with patient comfort and procedural efficiency in mind, featuring innovations, such as flexible materials for reduced patient discomfort and enhanced maneuverability. Additionally, the integration of safety mechanisms aims to minimize the risk of needlestick injuries, addressing a crucial concern in medical settings. These improvements not only facilitate a smoother surgical experience but also contribute to the precision and safety of medical procedures. The development of specialized cannulas tailored for specific applications, including microcannulas for delicate cosmetic procedures, underscores the commitment of the industry to innovation. Manufacturers are continuously investing in research operations, which is leading to the introduction of more advanced cannulas that meet the evolving needs of healthcare providers and patients.

• Growing Focus on Cosmetic Surgery:

The increasing acceptance and demand for cosmetic procedures, which often utilize cannulas for the injection of fillers, fat transfer, and other less invasive techniques, are contributing to the market growth. Moreover, technological advancements in the field are making cosmetic surgeries more accessible, safe, and affordable, expanding the market beyond traditional demographics. Procedures like liposuction, facial fillers, and fat transfer surgeries, which rely heavily on the use of cannulas, benefit from these advancements through reduced recovery times and minimized risks, appealing to a wider audience seeking aesthetic improvements. This not only drives the demand for specialized cannulas designed for cosmetic applications but also encourages continuous innovation in cannula technology to meet the high standards of safety and efficacy demanded by cosmetic surgery patients.

Leading Companies Operating in the Cannula Industry:

• Boston Scientific Corporation
• CONMED Corporation
• Edwards Lifesciences
• Medtronic Plc
• Smith & Nephew PLC
• Smiths Medical Inc.
• LivaNova Plc
• Teleflex Incorporated
• Terumo Corporation

Cannula Market Report Segmentation:

By Product:

• Cardiac Cannulas
• Nasal Cannulas
• Vascular Cannulas
• Dermatology Cannulas
• Arthroscopy Cannulas
• Others

Cardiac cannulas exhibit a clear dominance in the market, driven by the high prevalence of cardiovascular diseases among the masses and the increasing number of cardiac surgeries performed.

By Type:

• Neonatal Cannulas
• Straight Cannulas
• Winged Cannula
• Wing with Port Cannula
• Others

Straight cannulas represent the largest segment attributed to their ease of insertion and versatility in various medical procedures.

By Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

18G holds the biggest market share accredited to the optimal balance it provides between fluid flow rate and patient comfort.

By Material:

• Plastic (PVC) Cannulas
• Silicone Cannulas
• Metal Cannulas (Stainless Steel)

Plastic (PVC) cannulas account for the majority of the market share due to their cost-effectiveness, flexibility, and lower risk of allergic reactions.

By Application:

• Cardiovascular Surgery
• Oxygen Therapy
• General Surgery
• Cosmetic/Plastic Surgery
• Orthopedic Surgery
• Others 

On the basis of the application, the market has been segregated into cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopedic surgery, and others.

By End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Hospitals represent the largest segment, as they are the primary healthcare facilities where invasive procedures, including those requiring cannulation, are most commonly performed.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market owing to the presence of advanced healthcare infrastructure and a strong focus on research and development (R&D) in medical technologies.

Global Cannula Market Trends:

The advent of smart cannulas equipped with sensors and connectivity features is offering real-time monitoring of flow rates, pressure, and other critical parameters, enhancing the safety and effectiveness of procedures. This shift towards smart medical devices, leveraging the internet of things (IoT) and artificial intelligence (AI), enables personalized patient care and predictive maintenance, reducing the risk of complications and improving outcomes.

Furthermore, the development of biodegradable cannulas to reduce waste associated with single-use medical devices is bolstering the market growth. Manufacturers are exploring innovative materials and production methods that align with environmental sustainability goals while maintaining or even enhancing product performance.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145